HOME >> BIOLOGY >> NEWS
Molecular level discovery could play role in development of new antibiotics

CHAMPAIGN, Ill. -- Chemists at the University of Illinois at Urbana-Champaign have uncovered the molecular activity of an enzyme responsible for naturally turning a small protein into a potent antibiotic known as a lantibiotic.

The finding is described in the Jan. 30 issue of the journal Science. The research details how the enzyme performs two biosynthetic reactions that lead to the formation of fused cyclic structures required for antimicrobial activity. The discovery unlocks a door that could lead to a new line of antibiotic compounds based on nature's machinery, said Wilfred A. van der Donk, a professor of chemistry at Illinois.

The work was done using lacticin 481, a lantibiotic produced by one of several strains of Lactococcus lactis, a bacterium used in cheese production. Other lantibiotics are used to preserve other dairy products and canned vegetables. The lantibiotic nisin has been used for more than 50 years as an alternative to chemicals in food preservation in more than 40 countries without the development of significant antibiotic resistance.

"The use of antibiotics is an important area of medicine, because pathogenic bacteria are always in the environment," van der Donk said. "It's important to renew our arsenal of compounds that combat pathogens. With the development of resistance -- not just the kind that occurs through evolution but also the kind potentially created in biological weapons by terrorists -- we will always need new antibiotics."

The breakthrough in van der Donk's lab came in March 2003, when his doctoral student Lili Xie, now at the Harvard Medical School, noticed catalytic activity in the material she was investigating. Van der Donk had been pursuing such activity for six years. Many other labs have tried since the late 1980s, when the genes involved in nisin's biosynthetic pathway were sequenced, but efforts to make analogs in vitro had failed.

Lantibiotics are ribosomally synthesized a
'"/>

Contact: Jim Barlow, Life Sciences Editor
jebarlow@staff.uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
29-Jan-2004


Page: 1 2

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular therapeutics advance fight against brain cancer
7. Molecular motor shuttles key protein in response to light
8. Molecular traffic cop directs cellular signals
9. Molecular marker predicts success of breast cancer treatment
10. Molecular image of genotoxin reveals how bacteria damage human DNA
11. Molecular mechanism found that may improve ability of stem cells to fight disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... (PRWEB) , ... August 14, 2019 , ... ... broadcast 4Q/2019, will explore how developments in microbiome therapeutics are helping to promote ... listings for more information. , Advancements will educate about the DECODE.DESIGN.CURE™ technology platform, ...
(Date:8/14/2019)... ... 2019 , ... Join Anguraj Sadanandam, PhD, Team Leader, Systems ... (ICR) in a live webinar on Wednesday, September 4, 2019 at ... diagnostic development including machine learning approaches in different gastrointestinal cancers and their translational ...
(Date:8/6/2019)... ... August 05, 2019 , ... Keck Graduate Institute (KGI) President Sheldon Schuster has ... Sciences (SPHS). , “Dean Zdanowicz is highly regarded as an innovative leader who prioritizes ... is a great choice to build on the success of the KGI School of ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... 11, 2019 , ... At the most recent stem cell training course ... Veterans under the R3 Heroes Program. The Veterans included individuals and families from all ... anyone to nominate a military Veteran, teacher or first responder to receive a regenerative ...
(Date:6/18/2019)... ... June 17, 2019 , ... IVERIC ... into an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) vector ... autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 related ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... will add 80 of its scientific journals to DeepDyve’s rental service for peer-reviewed ... DeepDyve’s continually expanding library of more than 20 million articles, sourced from more ...
(Date:5/31/2019)... ... 2019 , ... For many years, the primary forms of cancer treatment have ... Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR ... receptors known as “CARs”. The CAR enables the final product to produce chemicals in ...
Breaking Biology Technology:
Cached News: